Armistice Capital, LLC Acurx Pharmaceuticals, Inc. Transaction History
Armistice Capital, LLC
- $5.71 Billion
- Q2 2025
A detailed history of Armistice Capital, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 1,078,540 shares of ACXP stock, worth $4.78 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,078,540Holding current value
$4.78 Million% of portfolio
0.01%Shares
6 transactions
Others Institutions Holding ACXP
# of Institutions
36Shares Held
2.69MCall Options Held
62.9KPut Options Held
56.9K-
Prospect Financial Services LLC Melville, NY367KShares$1.62 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$648,5690.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$644,7280.0% of portfolio
-
Morgan Stanley New York, NY106KShares$470,4700.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.8KShares$388,8690.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $51.2M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...